Charles Schwab Investment Management Inc Alaunos Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.43 - $0.65 $47,427 - $71,693	110,297 New	110,297 $56,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $187,602 - $567,383	-457,567 Reduced 84.65%	82,975 $103,000
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $19,139 - $33,186	17,559 Added 3.36%	540,542 $590,000
Q3 2021 Nov 16, 2021	SELL	$1.44 - $2.73 $1.38 Million - $2.61 Million	-955,802 Reduced 64.63%	522,983 $952,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $26,352 - $36,773	10,020 Added 0.68%	1,478,785 $3.9 Million
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $140,052 - $278,118	49,664 Added 3.5%	1,468,765 $5.29 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $56,613 - $83,701	27,088 Added 1.95%	1,419,101 $3.58 Million
Q3 2020 Nov 13, 2020	BUY	$2.39 - $3.43 $149,795 - $214,978	62,676 Added 4.71%	1,392,013 $3.51 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $335,904 - $566,457	152,684 Added 12.98%	1,329,337 $4.36 Million
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $334,639 - $877,107	176,126 Added 17.6%	1,176,653 $2.88 Million
Q4 2019 Feb 07, 2020	BUY	$3.95 - $5.35 $93,034 - $126,008	23,553 Added 2.41%	1,000,527 $4.72 Million
Q3 2019 Nov 08, 2019	BUY	$4.13 - $6.94 $323,622 - $543,811	78,359 Added 8.72%	976,974 $4.18 Million
Q2 2019 Aug 09, 2019	BUY	$3.98 - $6.2 $253,772 - $395,324	63,762 Added 7.64%	898,615 $5.24 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $4.4 $181,790 - $399,938	90,895 Added 12.22%	834,853 $3.22 Million
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $105,698 - $237,656	65,651 Added 9.68%	743,958 $1.39 Million
Q3 2018 Nov 13, 2018	SELL	$2.26 - $3.27 $80,297 - $116,183	-35,530 Reduced 4.98%	678,307 $2.17 Million
Q2 2018 Aug 08, 2018	BUY	$3.02 - $4.94 $149,837 - $245,098	49,615 Added 7.47%	713,837 $2.16 Million
Q1 2018 May 07, 2018	BUY	$3.46 - $5.14 $67,746 - $100,641	19,580 Added 3.04%	664,222 $2.6 Million
Q4 2017 Jan 17, 2018	BUY	$4.0 - $6.54 $104,212 - $170,386	26,053 Added 4.21%	644,642 $2.67 Million
Q3 2017 Nov 13, 2017	BUY	$4.99 - $6.57 $3.09 Million - $4.06 Million	618,589	618,589 $3.8 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account